Theravance Biopharma (TBPH)
(Real Time Quote from BATS)
$8.02 USD
0.00 (0.00%)
Updated Sep 25, 2024 09:50 AM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | -44.44% |
ABR | 2.20 |
Earnings ESP
|
-6.46% |
---|---|
Current Year | -0.45 |
Next Year | 0.75 |
EPS (TTM) | -0.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.11M | 34.22M | 79.17M | 108.76M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 16.31M | 66.83M | 111.61M | 130.59M |
Low Estimate | 16.00M | 17.00M | 62.00M | 91.00M |
Year ago Sales | 15.69M | 17.57M | 57.42M | 79.17M |
Year over Year Growth Est. | 2.68% | 94.76% | 37.87% | 37.37% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.05 | -0.45 | 0.75 |
# of Estimates | 3 | 2 | 2 | 3 |
Most Recent Consensus | -0.11 | -0.05 | -0.39 | 0.33 |
High Estimate | -0.08 | -0.05 | -0.39 | 1.06 |
Low Estimate | -0.12 | -0.05 | -0.51 | 0.33 |
Year ago EPS | -0.01 | 0.03 | -0.39 | -0.45 |
Year over Year Growth Est. | -900.00% | -266.67% | -15.38% | 267.41% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 3 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.05 | -0.45 | 0.75 |
7 Days Ago | -0.10 | -0.05 | -0.45 | 0.75 |
30 Days Ago | -0.09 | -0.02 | -0.39 | 0.73 |
60 Days Ago | -0.05 | 0.01 | -0.27 | 0.85 |
90 Days Ago | -0.05 | 0.01 | -0.27 | 0.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.05 | -0.39 | 0.33 |
Zacks Consensus Estimate | -0.10 | -0.05 | -0.45 | 0.75 |
Earnings ESP | -6.46% | 0.00% | 13.33% | -56.19% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.09 | 0.03 | -0.01 | NA |
Estimate | -0.09 | -0.19 | -0.04 | -0.10 | NA |
Difference | -0.04 | 0.10 | 0.07 | 0.09 | 0.06 |
Surprise | -44.44% | 52.63% | 175.00% | 90.00% | 68.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more